The impact of antimicrobial resistance (AMR), which causes drug-resistant infections, is a growing public health concern in every country in the world. This report gives an update on the status quo, recent developments and remaining critical gaps in the AMR response globally.
The findings are based on interviews with approximately 150 experts throughout 2019 and 2020, and reviews of more than 250 documents. The report includes:
The complexity of the AMR landscape, combined with a dearth of evidence allowing policymakers to quantify the relative contribution to resistance of different themes, has led to a state of paralysis.